radiopharmacy

Challenges and optimisation strategies for nuclear medicine and radiopharmacy in a crisis such as the COVID-19 pandemic and Brexit

The coronavirus pandemic (COVID-19) caused significant disruption to healthcare all over the world and interrupted patient care and service delivery. Limited access to healthcare, primarily to imaging services caused by cancellations and disruption to outpatient services due to extended lockdowns and travel restrictions, meant that the impact on patient care went beyond a diagnostic test. […]

Busola Ade-Ojo, Dr Ewa Nowosinska, Rohit Tiwari

Barts Health NHS Trust

Read Article

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.